Cancer Supportive Care Products Market To Reach US$ 40,884.0 Million By 2027

1. CANCER SUPPORTIVE CARE PRODUCTS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Cancer Supportive Care Products Market - Overview Cancer supportive care is associated with care given to the patients suffering from various types of cancer. Supportive care is intended for relieving suffering of the patients and improving their quality of life. Statistics: The global Cancer Supportive Care Products Market was estimated to account for US$ 27,244. Mn in terms of value by the end of 2019. Global Cancer Supportive Care Products Market: Drivers Availability of effective cancer supportive care products is expected to propel growth of the global cancer supportive care products market over the forecast period. For instance, according to a study presented at the recent Digital International Liver Congress (ILC 2020), Stivarga (regorafenib) and Opdivo (nivolumab), when administered as second-line treatments, equally improve survival for people with hepatocellular carcinoma (HCC), the most common type of liver cancer. Global Cancer Supportive Care Products Market: Opportunities R&D in drug delivery in cancer pain care is expected to offer lucrative growth opportunities for players in the global cancer supportive care products market. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/cancer- supportive-care-drugs-market-2013 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Key Takeaways: The global cancer supportive care products market was valued at US$ 27,244.1 Mn in 2019 and is forecast to reach a value of US$ 40,884.0 Mn by 2027 at a CAGR of 4.6% between 2020 and 2027.Increseing prevalence of cancer in developing and developed economies is expected to drive the market growth during the forecast period. Erythropoietin Stimulating Agents segment held dominant position in the global cancer supportive care products market in 2019, accounting for 24.7% share in terms of value, increasing research and development along with product approvals is expected to assist the segment growth during the forecast period. Market Trends Emergence of COVID‐19 has impacted cancer supportive care. For instance, the French Society of Pediatric Oncology, in September 2020, reported that, in a survey, out of the 12 centers that managed COVID‐19 patients, eight centers declared having postponed a specific oncologic treatment because of suspected or confirmed infection. Eight centers (28.6%) declared facing health care providers’ absenteeism because of infection. For instance, in August 2020, a quality improvement tool called “Improving Care Coordination: A Model for Lung Cancer” was released by the Association of Community Cancer Centers (ACCC). Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2013 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION There needs to be more emphasis on understanding the carryover effect between controlling chemotherapy induced emesis symptoms. As such, the EFPIA has recommended randomization of at least one drug approval trial Further, it is inappropriate to mention only one drug as a standard therapy e.g. NK1 receptor antagonist as a standard antiemetic therapy. It is better from the ethical standpoint to mention comparable drug data form the research perspective Global Cancer Supportive Care Products Market: Competitive Landscape Major players operating in the global cancer supportive care products market include, Amgen Inc., Johnson & Johnson Private Ltd., Merck, Novartis AG, Baxter International, Hoffmann-La Roche Ltd., Fagron, Teva Pharmaceutical Industries Ltd., G1 Therapeutics Inc., APR Applied Pharma Research s.a., Acacia Pharma, EMD Serono, and Kyowa Hakko Kirin Co., Ltd. Global Cancer Supportive Care Products Market: Key Developments Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, For instance, in August 2020, G1 Therapeutics Inc. received the U.S. FDA’s priority review designation to a new drug application (NDA) for trilaciclib for the treatment of patients with small cell lung cancer (SCLC) who are being treated with chemotherapy. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2013 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved